Android app on Google Play

Charles River Laboratories (CRL) Tops Q4 EPS by 4c

February 13, 2013 4:31 PM EST Send to a Friend
Get Alerts CRL Hot Sheet
Trade CRL Now!
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $0.64, $0.04 better than the analyst estimate of $0.60. Revenue for the quarter came in at $280.1 million versus the consensus estimate of $280.81 million.

Charles River Laboratories reaffirmed FY2013 guidance.

For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment